NasdaqGS - Delayed Quote USD

Accuray Incorporated (ARAY)

2.1900 +0.0100 (+0.46%)
At close: 4:00 PM EDT
2.1900 0.00 (0.00%)
After hours: 4:20 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Suzanne Winter M.B.A. President, CEO & Director 1.02M -- 1963
Mr. Ali Pervaiz Senior VP & CFO 601.12k -- 1980
Mr. Michael Hoge Senior Vice President of Global Operations 540.12k -- 1967
Mr. Jesse Chew Senior VP, Chief Legal Officer & Company Secretary 621.2k -- 1981
Mr. Sandeep Chalke Senior VP & Chief Commercial Officer 826.18k -- 1966
Ms. Gina Corradetti VP, Chief Accounting Officer, Principal Accounting Officer & Controller -- -- 1974
Mr. John M. Dunn Vice President, Chief Information & Security Officer -- -- --
Beth Kaplan Public Relations Director -- -- --
Ms. Melanie Gebauer Vice President of Global Human Resources -- -- --
Mr. Juki Hozumi President & GM of Japan Region -- -- --

Accuray Incorporated

1240 Deming Way
Madison, WI 53717-1954
United States
608 824 2800 https://www.accuray.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
1,024

Description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Corporate Governance

Accuray Incorporated’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 4; Board: 1; Shareholder Rights: 5; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 01, 2024
Accuray Incorporated Earnings Call

Related Tickers